A five-gene signature was linked to both event-free survival and overall survival in individuals with a type of rhabdomyosarcoma missing a prognostically informative gene fusion.
Array-based gene expression data suggests luminal and basal subtypes present in both human and canine forms of invasive urothelial carcinoma.
Researchers have developed a gene expression signature of healthy aging that can identify people at risk of Alzheimer's disease.
PrediXcan combines gene expression-level information with trait data to predict which genes likely play a role in heritable diseases and observed phenotypes.
Using a method that relied on Affymetrix arrays, researchers found that 38 patients in the trial had gene expression indicating they were in the ABC subtype.
Researchers used RNA interference and automated trait analyses to systematically track phenotypes in Caenorhabditis elegans worms from two genetic backgrounds.
The company is developing a test to predict RA patients' response to various drugs beginning with anti-TNF therapy, which it highlighted in a recent publication.
In three studies, researchers present new evidence on how gene expression differs across different tissues, and how DNA variations influence and alter this expression.
A team from Cincinnati Children's Hospital Medical Center has linked the expression of VNN1 to how well pediatric asthma patients respond to corticosteroid treatment.
New analytical approaches combine single-cell RNA-seq profiles with in situ gene expression markers to place sequenced cells in a spatial context.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.